About Establishment Labs
Establishment Labs is a company based in Alajuela (Costa Rica) founded in 2010. It operates as a B2B2C and HealthTech. Establishment Labs has raised $121 million across 10 funding rounds from investors including Perceptive Advisors, Madryn Asset Management and Crown Predator Holdings. The company has 1,020 employees as of December 31, 2024. Establishment Labs offers products and services including Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech. Establishment Labs operates in a competitive market with competitors including Sientra, GC Aesthetics, AirXpanders, BioAesthetics and Novasys Medical, among others.
- Headquarter Alajuela, Costa Rica
- Employees 1020 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Establishment Labs Holdings Inc.
-
Annual Revenue
$166.03 M (USD)0.53as on Dec 31, 2024
-
Net Profit
-$84.6 M (USD)-7.76as on Dec 31, 2024
-
EBITDA
-$42.41 M (USD)29.48as on Dec 31, 2024
-
Total Equity Funding
$121 M (USD)
in 10 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Jan 09, 2024
-
Investors
Perceptive Advisors
& 5 more
-
Employee Count
1020
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Establishment Labs
Establishment Labs is a publicly listed company on the NASDAQ with ticker symbol ESTA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Establishment Labs
Establishment Labs offers a comprehensive portfolio of products and services, including Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech.
Breast implants used for aesthetic augmentation procedures.
Ergonomic implants designed for natural breast augmentation.
Tissue expander for breast reconstruction post-cancer surgery.
Minimally invasive solution for breast harmony aesthetics.
People of Establishment Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Establishment Labs
Establishment Labs has successfully raised a total of $121M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Establishment Labs
Establishment Labs has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Perceptive Advisors, Madryn Asset Management and Crown Predator Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Single family office and private equity firm focused on healthcare, hedge funds, venture capital, and multiple sectors
|
Locked | Locked | Locked | |
|
Investment services are offered in healthcare and cannabis sectors.
|
Locked | Locked | Locked |
Investor details for Establishment Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Establishment Labs
Investment portfolio details for Establishment Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Establishment Labs
Detailed financials for Establishment Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Establishment Labs Comparisons
Peer comparison for Establishment Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Establishment Labs
Establishment Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sientra, GC Aesthetics, AirXpanders, BioAesthetics and Novasys Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products for plastic surgery and aesthetics are developed and marketed.
|
|
| Locked | Locked | Locked |
Silicone breast implants are developed for reconstruction and aesthetic surgery.
|
|
| Locked | Locked | Locked |
Tissue expansion technology for breast reconstruction surgery is developed.
|
|
| Locked | Locked | Locked |
Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use.
|
|
| Locked | Locked | Locked |
Therapeutics for female pelvic disorders, including SUI treatments, were developed.
|
Detailed competitors of Establishment Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Establishment Labs
Complete news archive for Establishment Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Establishment Labs
Establishment Labs was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Establishment Labs is headquartered in Alajuela, Costa Rica. It is registered at Alajuela, Alajuela, Costa Rica.
Juan Jose Chacon Quiros is the current CEO of Establishment Labs.
Establishment Labs is a funded company, having raised a total of $121M across 10 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Establishment Labs is 1,020.
Annual revenue of Establishment Labs is $166.03M as on Dec 31, 2024.
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving womens health through innovative Femtech solutions. The company specializes in breast health, aesthetics, and reconstruction, offering products like Motiva SmoothSilk implants for augmentation and Motiva Flora tissue expanders for reconstruction following breast cancer. Additionally, Mia Femtech provides minimally invasive breast harmony solutions. Supported by over 200 patent applications and 50 scientific studies, their offerings are grounded in science-based innovation. The company operates in multiple regions, including Costa Rica, Brazil, and Belgium, targeting healthcare providers and patients in the medical and aesthetic sectors.
Establishment Labs's top competitors include GC Aesthetics, Sientra and BioAesthetics.
Establishment Labs offers Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech.
Yes, Establishment Labs is publicly traded on NASDAQ under the ticker symbol ESTA.
Establishment Labs has 6 investors. Key investors include Perceptive Advisors, Madryn Asset Management, Crown Predator Holdings, JW Asset Management, and Rio Technology Partners.
The ticker symbol of Establishment Labs is ESTA on NASDAQ.